Piper Sandler: 'Solventum (SOLV) Continues to be Top Idea'

Piper Sandler analyst Jason Bednar reiterated an Overweight rating and $98.00 price target on Solventum (NYSE: SOLV).

The analyst commented: "Revenue Growth Keeps Getting Better, Continues to be Top Idea; SOLV reported 4Q results that included revenue of $1,998M/+3.5% organic and adj EPS of $1.57, all beats vs. Street and continuing what's been a pristine performance track record since IPO. Consistent with our preview call, management's 2026 guidance calls for a slight acceleration in underlying organic growth to +3-4%, while the midpoint of the $6.40-$6.60 EPS guide also settles ahead of the Street's $6.34. Simply put, there's a lot to like with the headline financials, and performance only looks to be getting better from here as momentum builds behind a realigned sales force, new product portfolio (20 NPIs next couple years), and the high-growth Acera asset. These fundamental performance factors more than outweigh any perceived AI-related risk (management downplayed that risk factor), in our opinion, and should support a meaningfully higher valuation than where shares currently trade. SOLV continues to be our top idea, PT remains $98."

For an analyst ratings summary and ratings history on Solventum click here. For more ratings news on Solventum click here.

Shares of Solventum closed at $76.94 yesterday.

You May Also Be Interested In

• Bernstein SocGen Group Starts Terawulf Inc. (WULF) at Outperform
• TEN Holdings (XHLD) files for 8M share offering
• Bitmine Immersion Technologies plans $300 million preferred stock offering